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documentation of cost data sources has improved over
the six years, and the use of previously published data has
decreased also. CONCLUSIONS: This preliminary study
reveals deﬁnite trends in the different data sources used
in economic evaluation over this six-year period. Whether
these trends can be seen regardless of disease area and
type of intervention remains to be investigated.
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OBJECTIVES: In a paper in the Journal of Health 
Economics, Victor Fuchs (2000) stated that one of the
main research tasks for health economists is to enhance
our understanding of economic behaviour. One of the
areas that are especially important for health economics
as a behavioural science is that, contrary to traditionally
assumed, people appear to be more concerned about 
relative than absolute levels of outcomes. METHODS:
First of all, in surveys of the relation between income and
wealth it was found that people take the behaviour and
wealth of relevant others as reference and, by the desire
to “live up to the Joneses”, adapt their preferences
according to this norm (i.e., “reference drift”). In addi-
tion, this “wealth” norm is affected by habituation to the
status quo individuals have already achieved. Each time
an aspiration level is reached, the norm is raised (i.e.,
“preference drift” or “adaptive preferences”). Is the same
true for health? Do people relate their health state, right
to health and health care to what is viewed as “normal”
or is possible in view of relevant others’ health?
RESULTS: Results from two surveys undertaken among
people from the general public (n = 220 & n = 394)
demonstrate that people adapt their expectations of
length and future quality of life to own health behaviour
relative to that of others and to age and health status of
close relatives. CONCLUSION: Therefore, after JS Mill,
people do not only desire to be healthy, but also as
healthy as others.
METHODOLOGY ISSUES—Quality of Life,
Evaluation, & Productivity Study Issues
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OBJECTIVES: A series of quality of life special interest
groups were set up by ISPOR in 1999 in order to stimu-
late discussion and contribute to the advancement of
science. The translation and cultural adaptation group
has met four times and has been working towards 
the development of a set of principles of best practice.
METHODS: The approach reviews and builds upon
current practice, taking account of existing guidelines and
theoretical perspectives. These diverse perspectives have
been evaluated with regard to the issues and challenges
facing industry and the broader outcomes research com-
munity. This approach seeks to be inclusive, taking into
account the views of practitioners, academics, and users
of health outcome measures. This ﬁrst stage has resulted
in an interim report describing the broadly agreed prin-
ciples of best practice. The next step will involve broad
consultation with practitioners, academics and users in
order to reﬁne and develop the interim report. This report
will set out objectives and principles and identify 
examples of best practice illustrated through a series of 
exemplary case studies. RESULTS: The initial draft of 
the paper is based upon a synthesis of methodological
approaches, common nomenclature, and quality-control
assurance requirements used by the range of organiza-
tions. The interim report provides both methods and
rationale for an expansive list of situations that are now
encountered with regularity. It also includes special pro-
tocols for a variety of unique considerations that have
arisen for translation/adaptation work that is sensitive to
expanding needs and challenges of outcomes research in
ever-expanding global applications. CONCLUSION:
This interim report provides a wealth of information and
guidance for Best Practice Principles in Cross-Cultural
Translation/Adaptation work. It is hoped that the 
presentation at this meeting will provide the starting 
point for the broader review so that a complete range of
perspectives can be taken into account.
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OBJECTIVE: Health economists developed QALYs in the
1970s as an outcome measure combining duration and
quality of life, primarily for use in cost-effectiveness
studies. The concept of the DALY, as developed for the
Global Burden of Disease (GBD) 1990 study, closely
resembled the QALY. We identiﬁed the analogies and dis-
parities of QALYs and DALYs from the literature and our
own empirical experience with both approaches (EQ-5D,
Dutch Disability Weights study). METHODS: The DALY
is a gap measure, deﬁning health loss from some prede-
ﬁned standard, whereas QALYs quantify health gains.
The general approach to derive QALY values includes
empirical valuation of generic health state descriptions,
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preferably using time trade-off, by a representative
sample from the general public. For the GBD-1990, 
disability weights (DWs) were derived for disease-speciﬁc
health state descriptions from an expert panel using
person trade-off. QALY values and DWs, respectively, are
combined with life-years directly and may be discounted,
whereas DALYs additionally included age weights.
RESULTS: We argue that, though apparent, the various
valuation methods and respondent panels are not the
most important differences. The important novelty of
DALYs lies in the derivation of disease speciﬁc disability
weights. Disease labeling adds information to an 
otherwise generic health state description and may have
added to the validity of the weights, but also disclosed
critical problems with the assumed utility independence
of survival and quality of life. The standard QALY
approach of summing separately valued one-year periods
appeared not to work for diseases characterized by rapid
transitions through different health states. CONCLU-
SION: The problems with DALYs uncovered some impor-
tant limitations of the standard QALY approach. This
may have important methodological implications for the
evaluation of the effects of interventions for attack-type
and short duration diseases.
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OBJECTIVE: Assessing Treatment Satisfaction (TS) has
become an important outcome for many trials and may
be the critical health outcome for differentiating drugs,
which have equal efﬁcacy. Unfortunately, most TS mea-
sures have not been developed according to appropriate
methodology to ensure reliability and validity. Addition-
ally, as with QoL, the choice to use a generic versus
disease speciﬁc measures can be problematic. This paper
will present and illustrate a solution to this problem by
demonstrating how a generic conceptual framework for
TS can be adapted for a diabetes disease speciﬁc measure.
METHOD: Building on a generic model of TS with
domains of efﬁcacy, side effects, willingness to use/rec-
ommend, impact on daily life, mode of delivery and 
convenience, diabetes disease speciﬁc deﬁnitions of these
domains were derived from patient focus groups and
expert interviews. Existing diabetes TS measures were
examined and limitations were identiﬁed. RESULTS: The
process for developing a generic/disease speciﬁc TS
measure was identiﬁed. Based on this process, a new
disease speciﬁc TS measure, the TSDQ (Treatment 
Satisfaction Diabetes Questionnaire) was developed. The
TSDQ, because it is based on a generic TS conceptual
model, is methodologically sound as well as being con-
ceptually grounded. This paper will identify limitations
with current TS measures, outline the process for 
developing methodological sound generic/disease speciﬁc
TS measures and present the TSDQ development. CON-
CLUSION: Using a generic conceptual model to develop
disease speciﬁc TS measures can help resolve the dilemma
of whether to use a generic or a disease speciﬁc measure.
This hybrid methodology for TS instrument development
will facilitate the promotion of TS claims and help to
solidify the scientiﬁc integrity of TS outcomes.
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OBJECTIVE: A common perspective of health econo-
mists involves the use of QALYs to prioritize activities,
given equal costs. In this mode of thinking, an activity
that took N people from a bad state to healthy for X years
should have priority over an activity that took N other
people from a bad state to a moderate state of health for
X years. In addition to prioritizing based on expected
outcome of the activity, QALY-thinking requires the 
prioritizing of treatment of the young over the old and
the treatment of those with healthy lifestyles over those
with unhealthy lifestyles (both based on longer expected
life-spans). This study was designed to investigate
whether this was the view shared by the general public 
of the United States. METHODS: This was done by 
surveying a cross-spectrum of subjects—including 
physicians, nurses, health administrators, as well as non-
healthcare workers. The survey consisted of six cases in
which the respondent was asked to prioritize two patients
who had presented to the emergency department, both
with life-threatening conditions requiring immediate
intervention. RESULTS: While the number of subjects
leaves room for interpretation, it would appear that inde-
pendent of ﬁeld of work, education level, age or sex,
approximately 80 percent of study participants tended to
emphasize equality in value of life and fairness in receiv-
ing treatment rather than expected quantity or quality of
life-years after the treatment.
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OBJECTIVES: It has been argued that gain in health state
valuation after intervention is smaller from a patient 
perspective than from a nonpatient perspective. In this
study we use hearing impairment as a research model to
test whether illness experience, personal or through
medical experience, inﬂuences gain in health state valua-
